Biogen Change Receivables vs Free Cash Flow Analysis

BIIB Stock

USD 158.01 2.01 1.29%

Biogen financial indicator trend analysis is way more than just evaluating Biogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biogen Inc is a good investment. Please check the relationship between Biogen Change Receivables and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Change Receivables vs Free Cash Flow

Change Receivables vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biogen Inc Change Receivables account and Free Cash Flow. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Biogen's Change Receivables and Free Cash Flow is 0.19. Overlapping area represents the amount of variation of Change Receivables that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Biogen Inc, assuming nothing else is changed. The correlation between historical values of Biogen's Change Receivables and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change Receivables of Biogen Inc are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Change Receivables i.e., Biogen's Change Receivables and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Change Receivables

The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 19.32, whereas Tax Provision is forecasted to decline to about 128.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	8.9B	7.9B	7.3B	3.9B
Total Revenue	11.0B	10.2B	9.8B	10.3B

Gross Profit Total Revenue

Biogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Common Stock	Short Term Debt
Total Assets		0.92	0.72	0.95	0.94	0.96	0.85	0.99	0.63	0.99	-0.57	0.61	0.96	-0.74	0.94	0.49	-0.82	0.96	0.86	0.93	0.59	0.89	-0.8	0.3	-0.8	0.4
Short Long Term Debt Total	0.92		0.64	0.86	0.76	0.89	0.96	0.9	0.58	0.9	-0.72	0.59	0.88	-0.62	0.98	0.42	-0.92	0.97	0.8	0.87	0.45	0.83	-0.63	0.33	-0.63	0.31
Other Current Liab	0.72	0.64		0.79	0.6	0.66	0.5	0.69	0.75	0.64	-0.45	0.86	0.68	-0.69	0.72	0.39	-0.67	0.75	0.29	0.81	0.03	0.69	-0.61	0.74	-0.61	0.42
Total Current Liabilities	0.95	0.86	0.79		0.85	0.92	0.75	0.91	0.72	0.92	-0.53	0.67	0.91	-0.74	0.89	0.34	-0.79	0.94	0.75	0.9	0.43	0.94	-0.74	0.34	-0.74	0.53
Total Stockholder Equity	0.94	0.76	0.6	0.85		0.89	0.68	0.94	0.56	0.93	-0.37	0.52	0.9	-0.73	0.78	0.52	-0.63	0.82	0.86	0.87	0.7	0.79	-0.85	0.18	-0.85	0.3
Property Plant And Equipment Net	0.96	0.89	0.66	0.92	0.89		0.82	0.92	0.59	0.96	-0.5	0.54	0.97	-0.78	0.92	0.44	-0.75	0.94	0.88	0.87	0.5	0.95	-0.78	0.21	-0.78	0.46
Net Debt	0.85	0.96	0.5	0.75	0.68	0.82		0.83	0.33	0.86	-0.7	0.38	0.82	-0.5	0.94	0.36	-0.86	0.91	0.81	0.73	0.54	0.71	-0.56	0.22	-0.56	0.25
Retained Earnings	0.99	0.9	0.69	0.91	0.94	0.92	0.83		0.63	0.97	-0.62	0.6	0.94	-0.66	0.92	0.46	-0.85	0.94	0.85	0.93	0.61	0.83	-0.73	0.28	-0.73	0.34
Cash	0.63	0.58	0.75	0.72	0.56	0.59	0.33	0.63		0.51	-0.41	0.9	0.59	-0.64	0.59	0.37	-0.6	0.64	0.3	0.83	-0.07	0.72	-0.47	0.52	-0.47	0.34
Non Current Assets Total	0.99	0.9	0.64	0.92	0.93	0.96	0.86	0.97	0.51		-0.55	0.49	0.95	-0.69	0.93	0.44	-0.78	0.95	0.91	0.86	0.67	0.86	-0.78	0.18	-0.78	0.41
Non Currrent Assets Other	-0.57	-0.72	-0.45	-0.53	-0.37	-0.5	-0.7	-0.62	-0.41	-0.55		-0.38	-0.54	0.14	-0.72	-0.13	0.87	-0.68	-0.46	-0.55	-0.26	-0.47	0.06	-0.2	0.06	-0.19
Cash And Short Term Investments	0.61	0.59	0.86	0.67	0.52	0.54	0.38	0.6	0.9	0.49	-0.38		0.52	-0.6	0.61	0.48	-0.6	0.64	0.18	0.84	-0.14	0.62	-0.55	0.83	-0.55	0.36
Net Receivables	0.96	0.88	0.68	0.91	0.9	0.97	0.82	0.94	0.59	0.95	-0.54	0.52		-0.75	0.91	0.4	-0.79	0.93	0.87	0.88	0.53	0.9	-0.74	0.18	-0.74	0.35
Common Stock Shares Outstanding	-0.74	-0.62	-0.69	-0.74	-0.73	-0.78	-0.5	-0.66	-0.64	-0.69	0.14	-0.6	-0.75		-0.64	-0.45	0.42	-0.68	-0.56	-0.75	-0.26	-0.8	0.85	-0.36	0.85	-0.3
Non Current Liabilities Total	0.94	0.98	0.72	0.89	0.78	0.92	0.94	0.92	0.59	0.93	-0.72	0.61	0.91	-0.64		0.44	-0.92	0.99	0.79	0.88	0.43	0.85	-0.65	0.37	-0.65	0.41
Other Current Assets	0.49	0.42	0.39	0.34	0.52	0.44	0.36	0.46	0.37	0.44	-0.13	0.48	0.4	-0.45	0.44		-0.25	0.42	0.38	0.54	0.24	0.36	-0.6	0.4	-0.6	0.01
Other Stockholder Equity	-0.82	-0.92	-0.67	-0.79	-0.63	-0.75	-0.86	-0.85	-0.6	-0.78	0.87	-0.6	-0.79	0.42	-0.92	-0.25		-0.9	-0.64	-0.82	-0.32	-0.71	0.37	-0.37	0.37	-0.35
Total Liab	0.96	0.97	0.75	0.94	0.82	0.94	0.91	0.94	0.64	0.95	-0.68	0.64	0.93	-0.68	0.99	0.42	-0.9		0.79	0.91	0.44	0.89	-0.69	0.37	-0.69	0.45
Property Plant And Equipment Gross	0.86	0.8	0.29	0.75	0.86	0.88	0.81	0.85	0.3	0.91	-0.46	0.18	0.87	-0.56	0.79	0.38	-0.64	0.79		0.67	0.78	0.76	-0.65	-0.17	-0.65	0.28
Total Current Assets	0.93	0.87	0.81	0.9	0.87	0.87	0.73	0.93	0.83	0.86	-0.55	0.84	0.88	-0.75	0.88	0.54	-0.82	0.91	0.67		0.35	0.85	-0.76	0.53	-0.76	0.34
Intangible Assets	0.59	0.45	0.03	0.43	0.7	0.5	0.54	0.61	-0.07	0.67	-0.26	-0.14	0.53	-0.26	0.43	0.24	-0.32	0.44	0.78	0.35		0.32	-0.53	-0.35	-0.53	-0.06
Accounts Payable	0.89	0.83	0.69	0.94	0.79	0.95	0.71	0.83	0.72	0.86	-0.47	0.62	0.9	-0.8	0.85	0.36	-0.71	0.89	0.76	0.85	0.32		-0.71	0.25	-0.71	0.52
Common Stock Total Equity	-0.8	-0.63	-0.61	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.74	0.85	-0.65	-0.6	0.37	-0.69	-0.65	-0.76	-0.53	-0.71		-0.36	1.0	-0.23
Short Term Investments	0.3	0.33	0.74	0.34	0.18	0.21	0.22	0.28	0.52	0.18	-0.2	0.83	0.18	-0.36	0.37	0.4	-0.37	0.37	-0.17	0.53	-0.35	0.25	-0.36		-0.36	0.27
Common Stock	-0.8	-0.63	-0.61	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.74	0.85	-0.65	-0.6	0.37	-0.69	-0.65	-0.76	-0.53	-0.71	1.0	-0.36		-0.23
Short Term Debt	0.4	0.31	0.42	0.53	0.3	0.46	0.25	0.34	0.34	0.41	-0.19	0.36	0.35	-0.3	0.41	0.01	-0.35	0.45	0.28	0.34	-0.06	0.52	-0.23	0.27	-0.23

Click cells to compare fundamentals

Biogen Account Relationship Matchups

Biogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Short Long Term Debt Total	6.4B	7.8B	7.6B	6.6B	7.3B	7.7B
Other Current Liab	3.4B	3.1B	2.4B	2.4B	1.4B	945.6M
Total Current Liabilities	4.9B	3.7B	4.3B	3.3B	3.4B	3.6B
Total Stockholder Equity	13.3B	10.7B	11.0B	13.4B	14.8B	15.5B
Property Plant And Equipment Net	3.7B	3.8B	3.8B	3.7B	3.7B	3.9B
Net Debt	3.5B	6.5B	5.3B	3.2B	6.3B	6.6B
Retained Earnings	16.5B	14.0B	13.9B	16.5B	17.6B	18.5B
Cash	2.9B	1.3B	2.3B	3.4B	1.0B	723.1M
Non Current Assets Total	18.9B	17.7B	16.0B	14.8B	20.0B	21.0B
Non Currrent Assets Other	(3.2B)	(1.4B)	1.9B	1.5B	284.3M	270.1M
Cash And Short Term Investments	4.5B	2.6B	3.8B	4.9B	1.0B	1.5B
Net Receivables	1.9B	2.3B	2.0B	2.1B	2.1B	2.2B
Common Stock Shares Outstanding	187.4M	161.3M	149.6M	146M	145.6M	283.0M
Liabilities And Stockholders Equity	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Non Current Liabilities Total	9.0B	10.2B	8.6B	7.9B	8.6B	9.0B
Other Current Assets	1.2B	881.1M	740.8M	1.4B	1.2B	1.2B
Other Stockholder Equity	(3.0B)	(3.0B)	(2.9B)	(2.9B)	(2.7B)	(2.5B)
Total Liab	13.9B	13.9B	12.9B	11.2B	12.0B	12.6B
Property Plant And Equipment Gross	3.7B	3.8B	3.8B	3.7B	6.1B	6.4B
Total Current Assets	8.4B	6.9B	7.9B	9.8B	6.9B	7.2B
Accumulated Other Comprehensive Income	(135.2M)	(299M)	(106.7M)	(164.9M)	(153.7M)	(146.0M)
Intangible Assets	3.5B	3.1B	2.2B	1.9B	8.4B	8.8B
Accounts Payable	530.8M	454.9M	589.2M	491.5M	403.3M	423.5M
Short Term Investments	2.3B	1.6B	1.3B	1.5B	1.5B	0.0
Inventory	804.2M	1.1B	1.4B	1.3B	2.5B	2.7B
Other Liab	4.2B	2.4B	2.0B	1.3B	1.5B	969.6M
Other Assets	3.2B	4.2B	3.4B	1.7B	1.9B	2.0B
Long Term Debt	4.5B	7.4B	6.3B	6.3B	6.8B	7.1B
Property Plant Equipment	3.2B	3.4B	3.4B	3.3B	3.8B	2.1B
Good Will	5.8B	5.8B	5.8B	5.7B	6.2B	3.2B
Net Tangible Assets	4.1B	1.9B	2.9B	5.8B	6.7B	4.1B
Noncontrolling Interest In Consolidated Entity	(4.1M)	(14.2M)	63.5M	(9.5M)	(8.6M)	(8.1M)
Retained Earnings Total Equity	16.5B	14.0B	13.9B	16.5B	18.9B	11.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.02)

Earnings Share

11.06

Revenue Per Share

66.122

Quarterly Revenue Growth

(0.03)

Return On Assets

0.0499

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Change Receivables vs Free Cash Flow Analysis

Change Receivables vs Free Cash Flow

Change Receivables vs Free Cash Flow Correlation Analysis

Correlation Coefficient

Change Receivables

Free Cash Flow

Biogen fundamental ratios Correlations

Biogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biogen fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Retained Earnings	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Total Liab	+ 0.97	Short Long Term Debt Total

Other Stockholder Equity	- 0.92	Non Current Liabilities Total
Other Stockholder Equity	- 0.92	Short Long Term Debt Total
Total Liab	- 0.9	Other Stockholder Equity
Other Stockholder Equity	- 0.86	Net Debt
Other Stockholder Equity	- 0.85	Retained Earnings
Common Stock	- 0.85	Total Stockholder Equity